1. Eeley L: Intensive therapy in type 2 diabetes: the United Kingdom Prospective Diabetes Study. Diabetes Care and Education: On The Cutting Edge21:11-14, 2000.
2.
2. Nutrition Subcommittee, British Diabetic Association: Dietary recommendations for diabetics for the 1980s. Human Nutr Appl Nutr36A:378-394, 1982.
3.
3. UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet352:837-853, 1998.
4.
4. Eeley EA, Stratton IM, Hadden DR, on behalf of the UKPDS: Estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulfonylurea, or insulin therapy (UKPDS 18). Diabetic Med13:656-662, 1996.
5.
5. UK Prospective Diabetes Study Group: Response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients (UKPDS 7). Metabolism39:905-912,1990.
6.
6. UK Prospective Diabetes Study Group: Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose control or blood pressure control. Diabetes Care22:1125-1136, 1999.
7.
7. Bloomgarden ZT: European Association for the Study of Diabetes Annual Meeting, 1999. Diabetes Care23:1016-1016, 2000.
8.
8. Wing RR, Koeske R, Epstein LH, Nowalk MP, Gooding W, Becker D: Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med147:1749-1753,1987.
9.
9. Watts NB, Spanheimer RG, DiGirolamo M, Gebhart SS, Musey VC, Siddiq K, Phillips LS: Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus. Arch Intern Med150:803-806, 1990.
10.
10. Wing RR, Blair EH, Bononi P, Marcus MD, Watanabe R, Bergman RN: Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care17:30-36, 1994.
11.
11. Kelly DE, Wing R, Buonocore P, Sturis J, Polonsky K, Fitzsimmons M: Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab77:1287-1293,1993.
12.
12. Markovic TP, Jenkins AB, Campbell LV, Furler SM, Kraegen EW, Chisholm DJ: The determinants of glycemic responses to diet restriction and weight loss in obesity and NIDDM. Diabetes Care21:687-694,1998.
13.
13. Markovic TP, Campbell LV, Balasubramanian S, Jenkins AB, Fleury AC, Simons LA, Chisholm DJ: Beneficial effect on average lipid levels from energy restriction and fat loss in obese individuals with or without type 2 diabetes. Diabetes Care21:695-700,1998.
14.
14. Harris MI: Classification, diagnostic criteria, and screening for diabetes. In: Diabetes in America. 2nd ed.Harris MI, Ed. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIH publ. no. 95-1468), 1995, p. 15-35.
15.
15. Franz MJ, Monk A, Barry B, McClain K, Weaver T, Cooper N, Upham P, Bergenstal R, Mazze RS: Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial. J Am Diet Assoc95:1009-1017,1995.
16.
16. Foreyt JP, Goodrick GK: Evidence for success of behavior modification in weight loss and control. Ann Intern Med119:698-701,1992.
17.
17. Brownell KD, Rodin J: The dieting maelstrom: is it possible and advisable to lose weight?Am Psychol49:781-791,1994.
18.
18. Brownell KD, Wadden TA: Etiology and treatment of obesity: understanding a serious, prevalent, and refractory disorder. J Consult Clin Psychol60:505-517,1992.
19.
19. Liebel RL, Rosenbaum M, Hirsch J: Changes in energy expenditure resulting from altered body weight. N Engl J Med332:621-628,1995.
20.
20. Polivy J: Psychological consequences of food restriction. J Am Diet Assoc96:589-592,1996.
21.
21. Bender R, Trautner C, Spraul M, Berger M: Assessment of excess mortality in obesity. Am J Epidemiol147:42-48,1998.
22.
22. Chaturvedi N, Fuller JH, The WHO Multinational Study of Vascular Disease in Diabetes: Mortality risk by body weight and weight change in people with NIDDM. Diabetes Care18:766-774,1995.
23.
23. Chaturvedi N, Stevens LK, Fuller JH, The WHO Multinational Study of Vascular Disease in Diabetes: Mortality and morbidity associated with body weight in people with IDDM. Diabetes Care18:761-765, 1995.
24.
24. Klein R, Klein B, Moss SE: Is obesity related to microvascular and macrovascular complications of diabetes?Arch Intern Med157:650-656,1997.
25.
25. Bo S, Gentile L, Cavallo-Perin P, Vincis P, Ghia V: Sex and BMI-related differences in risk factors for coronary artery disease in patients with type 2 diabetes mellitus. Acta Diabetol36:147-153,1999.
26.
26. Turner RC, Millns H, Neil HAW, Stratton IM, Manley SE, Matthews DR, Holman RR, for the United Kingdom Prospective Diabetes Study: Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS 23). Br Med J316:823-828,1998.
27.
27. Barlow CE, Kohl HW, Gibbons LW, Blair SN: Physical fitness, mortality and obesity. Int J Obes19 (Suppl. 4):S41-44, 1995.
28.
28. Redmon JB, Raatz SK, Kwong CA, Swanson JE, Thomas W, Bantle JP: Pharmacologic induction of weight loss to treat type 2 diabetes. Diabetes Care22:896-903, 1999.
29.
29. Moore LL, Visioni AJ, Wilson PWF, D'Agostino RB, Finkle WD, Ellison RC: Can sustained weight loss in overweight individuals reduce the risk of diabetes mellitus?Epidemiology11:269-273, 2000.
30.
30. The Diabetes Prevention Program Research Group: The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care22:623-634,1999.
31.
31. Monk A, Barry B, McClain K, Weaver T, Cooper N, Franz MJ: Practice guidelines for medical nutrition therapy by dietitians for persons with non-insulin-dependent diabetes mellitus. J Am Diet Assoc95:999-1008,1995.
32.
32. Gillespie S, Kulkarni K, Daly A: Using carbohydrate counting in diabetes clinical practice. J Am Diet Assoc98:897-899,1998.
33.
33. Rickheim P, Flader J, Carstensen KM: Type 2 Diabetes BASICS: A Complete Curriculum for Diabetes Education. Minneapolis, MN, International Diabetes Center2000.
34.
34. Yamanouchi K, Shinozaki T, Chikada K, Nishikawa T, Ito K, Shimizu S, Ozawa N, Suzuki Y, Maeno H, Kato K, Oshida Y, Sato Y: Daily walking combined with diet therapy is a useful means for obese NIDDM patients not only to reduce body weight but also to improve insulin sensitivity. Diabetes Care18:775-777,1995.
35.
35. Mayer-Davis EJ, D'Agostino RJ, Karter AJ, Haffner SM, Rewers MJ, Saad M, Bergman RN, for the IRAS Investigators. Intensity and amount of physical activity in relation to insulin sensitivity: The Insulin Resistance and Atherosclerosis Study (IRAS). JAMA270:669-674,1998.
36.
36. Sato Y, Igudi A, Sakamoto N: Biochemical determination of training affects using insulin clamp technique. Hormone Metab Res16:483-486,1984.
37.
37. Schneider SH, Khachadurian AK, Amorosa LF, et al: Ten-year experience with exercise-based outpatient life-style modification program in the treatment of diabetes mellitus. Diabetes Care15:1800-1810, 1992.
38.
38. Soukup JT, Kovaleski JE: A review of the effects of resistance training for individuals with diabetes mellitus. Diabetes Educ19:307-312, 1993.
